棕化驱动的免疫调节失调和低度质瘤的预后特征:一个多奥米克和功能验证研究
Zehao Wang1, Tianlun Yu2, Yuqiao Liu1
1School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Frontiers in pharmacology
|June 19, 2025
概括
棕化会影响低度质瘤的进展和免疫反应. 一个新的五基因签名有助于风险分层,确定IGFBP2作为改善患者结果的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 棕化是一种关键的翻译后修改,影响癌症中的蛋白质功能.
- 它在质瘤进展,免疫调节和患者预后方面的具体作用尚不清楚.
研究的目的:
- 调查棕细胞代谢在低度质瘤 (LGG) 进展中的作用.
- 确定预后生物标志物,并开发LGG的风险特征.
- 探索LGG中棕化,免疫透和免疫治疗反应之间的关系.
主要方法:
- 来自多中心LGG队列的综合转录组,临床和突变数据.
- 利用共识聚类,差异表达分析和LASSO回归来定义棕化聚类并构建风险特征.
- 使用siRNA淘汰和体外试验 (EdU,细胞周期,迁移) 进行IGFBP2的功能验证.
主要成果:
- 确定了两种棕化团 (A/B),其中团B与较差的存活率,丰富的JAK-STAT信号和增加的免疫透有关.
- 开发了一种具有高预测精度的五基因预后特征 (CHI3L1,IGFBP2,MEOX2,EMILIN3,SFRP2).
- 高风险患者表现出高调的免疫检查点分子 (PD-1,PD-L1,CTLA4) 和更高的TIDE分数,表明免疫功能障碍. IGFBP2 敲击抑制了结质瘤细胞的增殖和迁移.
结论:
- 棕化显著影响LGG进展,免疫逃逸和 stromal 相互作用.
- 开发的预后签名和名图为临床风险分层提供了有价值的工具.
- IGFBP2成为一个有前途的治疗点,突出了向棕化通路的潜力,以改善LGG患者的治疗结果.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K